90
Participants
Start Date
June 30, 2015
Primary Completion Date
December 31, 2017
Study Completion Date
December 31, 2017
Atazanavir 200 mg/r
"1. In patients signed an informed consent and meeting all the eligibility criteria at the time of the run-in (S-4),~2. switch of antiretroviral therapy Atazanavir 300 mg/ritonavir 100 mg once a day to Atazanavir 200 mg/ritonavir 100 mg once a day without changing the combination of 2 NRTIs associated.~The administration will be done once a day orally for 48 weeks.~The usual recommended dose of atazanavir is 300 mg once daily with 100 mg of ritonavir once daily with food. Ritonavir acts by potentiating the pharmacokinetics of atazanavir."
DUDOIT Yasmine, Paris
INSERM UMR S 1136
OTHER
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
OTHER